SCHEMBL7435587

SCHEMBL7435587

CCCCNC(=O)N(C(=O)NCCCC)c1c(OC(=O)N(CC)CC)nc(C)c2cc(OC)c(OC)cc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
QPCT Q16769 3/20 0.38
KDR P35968 3/20 0.38
LMNA P02545 1/20 0.37
PDE10A Q9Y233 2/20 0.37
PSMB5 P28074 1/20 0.36
PSMB2 P49721 1/20 0.36
APAF1 O14727 1/20 0.35
TDP2 O95551 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GAA P10253 1/20 0.35
MAPK1 P28482 1/20 0.35
CASP3 P42574 1/20 0.35
SENP8 Q96LD8 1/20 0.35
HSD17B10 Q99714 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
LTK P29376 1/20 0.35
CSNK1A1 P48729 1/20 0.35
KCNH2 Q12809 1/20 0.35
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7440283 0.82 KDR (0.44) QPCTKDRLMNAPDE10APSMB5
SCHEMBL7440286 0.79 LMNA (0.35) QPCTLMNAALDH1A1GAAHSD17B10
SCHEMBL7447594 0.77 LCK (0.41) KDRALDH1A1GAAHSD17B10
SCHEMBL7426725 0.76 LMNA (0.43) LMNAPDE10AALDH1A1GAA
SCHEMBL7447598 0.75 TSPO (0.34) LMNAHSD17B10
SCHEMBL7446891 0.73 LMNA (0.41) LMNAPDE10AALDH1A1HSD17B10
SCHEMBL7441183 0.72 LMNA (0.39) LMNAPDE10AALDH1A1CASP3SENP8
SCHEMBL7436056 0.71 KDR (0.42) KDRPDE10APSMB5PSMB2APAF1
SCHEMBL7495451 0.69 TNFSF11 (0.39) PDE10AGAAHSD17B10
SCHEMBL7436061 0.68 KMT2A (0.32) LMNAPDE10AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4880817-A O-functionalized derivatives of substituted isoquinolin-3-ols having cardiotonic and/or phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties ORTHO PHARMACEUTICAL CORPORATION (US) 1989-11-14 US disclosed